Emergent Biosolutions, Inc. (EBS) is trading at $5.08 up 5.39% over the past 24 hours. Its Galaxy Score is 41.1, LunarCrush's combined measure of market and social performance. Over the last 24 hours it has seen 924 engagements and 16 posts with 65% positive social sentiment.
AI summary: Emergent BioSolutions Inc. (EBS) biodefense vaccine developer tied to PAHPA-funded ACAM2000 contract amid policy timing uncertainty. Contract win supports near-term deliveries, but policy timing uncertainty caps upside and keeps shares near 52-week lows.